Why Moderna Topped the Market Today
Moderna is greatly expanding its arrangement with Taiwan. The biotech company has signed on to provide 20 million doses of its mRNA-1273 coronavirus vaccine and its updated variant booster vaccine (if authorized for use) in 2022. Moderna did not disclose the financial terms of the expanded deal.